An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

10.1002/pbc.26887

Saved in:

Bibliographic Details
Main Authors:	Dionne, Francois, Aminkeng, Folefac, Bhavsar, Amit P, Groeneweg, Gabriella, Smith, Anne, Visscher, Henk, Rassekh, Shahrad Rod, Ross, Colin, Carleton, Bruce
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Hematology Pediatrics anthracyclines cardiotoxicity dexrazoxane pharmacogenomics testing HEART-FAILURE DOXORUBICIN CARDIOTOXICITY CHILDREN DEXRAZOXANE PREVENTION MORTALITY SURVIVORS THERAPY LEUKEMIA SARCOMA
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235044
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-235044
record_format	dspace
spelling	sg-nus-scholar.10635-2350442024-04-17T09:53:30Z An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines Dionne, Francois Aminkeng, Folefac Bhavsar, Amit P Groeneweg, Gabriella Smith, Anne Visscher, Henk Rassekh, Shahrad Rod Ross, Colin Carleton, Bruce MEDICINE Science & Technology Life Sciences & Biomedicine Oncology Hematology Pediatrics anthracyclines cardiotoxicity dexrazoxane pharmacogenomics testing HEART-FAILURE DOXORUBICIN CARDIOTOXICITY CHILDREN DEXRAZOXANE PREVENTION MORTALITY SURVIVORS THERAPY LEUKEMIA SARCOMA 10.1002/pbc.26887 PEDIATRIC BLOOD & CANCER 65 3 2022-12-01T05:56:57Z 2022-12-01T05:56:57Z 2018-03-01 2022-11-30T16:23:56Z Article Dionne, Francois, Aminkeng, Folefac, Bhavsar, Amit P, Groeneweg, Gabriella, Smith, Anne, Visscher, Henk, Rassekh, Shahrad Rod, Ross, Colin, Carleton, Bruce (2018-03-01). An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines. PEDIATRIC BLOOD & CANCER 65 (3). ScholarBank@NUS Repository. https://doi.org/10.1002/pbc.26887 1545-5009 1545-5017 https://scholarbank.nus.edu.sg/handle/10635/235044 en WILEY Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology Hematology Pediatrics anthracyclines cardiotoxicity dexrazoxane pharmacogenomics testing HEART-FAILURE DOXORUBICIN CARDIOTOXICITY CHILDREN DEXRAZOXANE PREVENTION MORTALITY SURVIVORS THERAPY LEUKEMIA SARCOMA
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology Hematology Pediatrics anthracyclines cardiotoxicity dexrazoxane pharmacogenomics testing HEART-FAILURE DOXORUBICIN CARDIOTOXICITY CHILDREN DEXRAZOXANE PREVENTION MORTALITY SURVIVORS THERAPY LEUKEMIA SARCOMA Dionne, Francois Aminkeng, Folefac Bhavsar, Amit P Groeneweg, Gabriella Smith, Anne Visscher, Henk Rassekh, Shahrad Rod Ross, Colin Carleton, Bruce An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
description	10.1002/pbc.26887
author2	MEDICINE
author_facet	MEDICINE Dionne, Francois Aminkeng, Folefac Bhavsar, Amit P Groeneweg, Gabriella Smith, Anne Visscher, Henk Rassekh, Shahrad Rod Ross, Colin Carleton, Bruce
format	Article
author	Dionne, Francois Aminkeng, Folefac Bhavsar, Amit P Groeneweg, Gabriella Smith, Anne Visscher, Henk Rassekh, Shahrad Rod Ross, Colin Carleton, Bruce
author_sort	Dionne, Francois
title	An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
title_short	An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
title_full	An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
title_fullStr	An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
title_full_unstemmed	An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
title_sort	initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines
publisher	WILEY
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/235044
_version_	1800915742571364352

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

Similar Items